In the seven articles that included HER2-zero, HER2-low, and HER2-positive tumors [20–23, 27–29], histological tumor type data were sourced from four articles [20, 21, 27, 29], revealing a prevalence of 87.1% for ductal carcinoma. The gene discussed is ERBB2; the disease is breast ductal adenocarcinoma.